Response to Oral Immediate‐Release Opioids for Breakthrough Pain in Patients With Advanced Cancer With Adequately Controlled Background Pain

Oncologist - United States
doi 10.1634/theoncologist.2017-0583
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Evidence-Based Treatment of Cancer-Related Breakthrough Pain With Opioids

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Safety Profile of Prophylactic Rescue Dosing of Immediate-Release Oral Opioids in Cancer Patients

Journal of Pharmaceutical Health Care and Sciences
2018English

Heart Rate Variability During Treatment of Breakthrough Pain in Patients With Advanced Cancer: A Pilot Study

Journal of Pain Research
AnesthesiologyPain Medicine
2016English

Nitrous Oxide/Oxygen Mixture for Analgesia in Adult Cancer Patients With Breakthrough Pain: A Randomized, Double-Blind Controlled Trial

European Journal of Pain
MedicineAnesthesiologyPain Medicine
2017English

Opioids for Chronic Non-Cancer Pain

British Medical Journal
Medicine
2013English

Opioids for Chronic Non-Cancer Pain

2019English

Intravenous Opioids in Chronic Cancer Pain.

BMJ
1985English

Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Role of Intranasal Fentanyl in Breakthrough Pain Management in Cancer Patients

Cancer Management and Research
Oncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy